|
UBE2I expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.52159999994495E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.056440E-02 |
| Stage1-vs-Stage3 |
3.395800E-01 |
| Stage1-vs-Stage4 |
4.057900E-03 |
| Stage2-vs-Stage3 |
5.236200E-03 |
| Stage2-vs-Stage4 |
8.31050000000833E-05 |
| Stage3-vs-Stage4 |
5.670100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.1262999977113E-08 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
6.696800E-01 |
| Caucasian-vs-Asian |
5.459400E-01 |
| AfricanAmerican-vs-Asian |
9.849800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.319400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.71407332771878E-12 |
| Normal-vs-Age(81-100Yrs) |
2.195800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.563200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.827900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.665200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.239620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.503800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.222600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.896400E-02 |
| Classical-VS-Follicular |
1.72473146875518E-12 |
| Classical-VS-Other |
2.241200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
8.69949667858805E-11 |
| Tall-VS-Other |
5.370400E-02 |
| Tall-VS-Normal |
1.62492241884138E-12 |
| Follicular-VS-Other |
1.360240E-01 |
| Follicular-VS-Normal |
9.390000E-04 |
| Other-VS-Normal |
2.801600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
9.99200722162641E-16 |
| N0-vs-N1 |
5.479800E-03 |
|
|
